Stuff co.nz 9 September 2011
The Drug Foundation is disappointed the Government has rejected calls to carry out medicinal cannabis trials but says the door remains open for pharmaceutical companies to run their own tests.
The Government yesterday released its response to the Law Commission’s May report on drug laws which contained 144 recommendations.
Associate Health Minister Peter Dunne said the Government agreed the 1975 Misuse of Drugs Act needed to be rewritten and that task would be undertaken by the incoming government because it was important the issues were not rushed.
The Government would not be adopting the recommendation it conduct clinical trials into the medical use of leaf cannabis.
Drug Foundation executive director Ross Bell said science supported medicinal cannabis for some illnesses including multiple sclerosis, chronic pain where other medications were ineffective and as an appetite booster for HIV/Aids and cancer patients.
“A lot of people think that medicinal cannabis is a backdoor way into trying to legalise cannabis. We absolutely don’t agree with that.”
However, New Zealand needed to ensure it didn’t to allow “back door legalisation” like California had, he said.